feed,title,long_url,short_url
Yahoo,Gossamer Bio's stock falls 64% on findings for Phase 2 study for hypertension drug,https://www.marketwatch.com/story/gossamer-bios-stock-falls-64-on-findings-for-phase-2-study-for-hypertension-drug-2022-12-06?siteid=yhoof2&yptr=yahoo,https://on.mktw.net/3YdFWwD
